Indian drugmaker Aurobindo Pharma reported a lower first-quarter profit on Monday, as expenses grew faster than revenue - stung by weak prices in the key U.S. market.

Aurobindo Pharma reported a 10.2% YoY decline in Q1 net profit to ₹824.2 crore, missing CNBC-TV18 estimates. Revenue rose 4%, ...

Aurobindo Pharma Ltd. reported a 10.3 per cent year-on-year (YoY) decline in consolidated net profit to Rs 824.2 crore in Q1 ...

Asian markets opened higher amid positive global cues. Last checked, Japan's Nikkei 225 index was trading 0.42 per cent ...

Key stocks to watch on August 5 include DLF, Aurobindo Pharma, LTIMindtree, Sona BLW, Paytm, and more, following key earnings ...

Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...

Stocks including Paytm, Aditya Infotech, Bosch, Laxmi India Finance, Aurobindo Pharma, DLF, Bharti Airtel, Siemens Energy and ...

Domestic equity benchmarks halted a two-day losing streak amid buying in IT, energy and auto shares on Monday, though selling ...

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter ...

Aurobindo Pharma's revenue increased by 4% year-on-year for the three months ended June, reaching Rs 7,868 crore.

Aurobindo Pharma reports a 10% decline in consolidated net profit to Rs 824 crore for the June quarter, due to dwindling ...

Shree Cements, Aurobindo Pharma, DLF, Siemens Energy, Bosch, and Marico among 192 companies to release earnings report today.